Swiss National Bank Kala Pharmaceuticals, Inc. Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$1.16 - $2.74 $102,312 - $241,668
-88,200 Closed
0 $0
Q2 2021

Aug 06, 2021
BUY
$5.06 - $8.15 $62,743 - $101,060
12,400 Added 16.36%
88,200 $467,000
Q3 2020

Nov 09, 2020
BUY
$7.5 - $11.11 $20,250 - $29,997
2,700 Added 3.69%
75,800 $569,000
Q2 2020

Aug 05, 2020
BUY
$8.33 - $13.79 $608,923 - $1.01 Million
73,100 New
73,100 $768,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.9M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email